Artificial Intelligence MarketSize, Share & Industry Analysis, 2026-2034By SolutionBy TechnologyBy End-useBy LawBy Deployment Mode
Full title & scope — all 5 axes with their segments
Artificial Intelligence Market Size, Share & Industry Analysis, By Solution (Hardware, Software, Services), By Technology (Machine Learning, Deep Learning, Natural Language Processing, Machine Vision), By End-use (Healthcare, Robot-Assisted Surgery, Virtual Nursing Assistants, Hospital Workflow Management, Dosage Error Reduction, Clinical Trial Participant Identifier, Preliminary Diagnosis, Automated Image Diagnosis, BFSI, Risk Assessment, Financial Analysis/Research, Investment/Portfolio Management, Others), By Law (Retail, Advertising & Media, Automotive & Transportation, Agriculture, Manufacturing, Others), By Deployment Mode (Cloud, On-Premise), and Regional Forecast, 2026-2034
Full table of contents for the published report, chapter by chapter.

- 01By SolutionHardware · Software · Services
- 02By TechnologyMachine Learning · Deep Learning · Natural Language Processing
- 03By End-useHealthcare · Robot-Assisted Surgery · Virtual Nursing Assistants
- 04By LawRetail · Advertising & Media · Automotive & Transportation
- 05By Deployment ModeCloud · On-Premise
- 06By Region
Market Analysis & Outlook
Artificial intelligence covers software, hardware and services that let systems learn from data and perform tasks that normally require human judgment, spanning machine learning platforms, purpose-built processors and accelerators, and the algorithms and models built on top of them. Buyers range from technology vendors embedding AI into their own products to enterprises across healthcare, financial services, retail, manufacturing, automotive and media that deploy it for diagnosis support, risk scoring, demand forecasting, process automation and content generation. The scope covers packaged software, dedicated hardware and the consulting, integration and managed services that accompany deployment, across on-premise and cloud delivery.
Between 2025 and 2034 the global artificial intelligence market moves from USD 300 billion to USD 1400 billion, compounding at 17.55% a year. Fifteen years are covered in all, taking in USD 66.8 billion in 2020, USD 227.1 billion in 2024, USD 384 billion in 2026 and USD 833 billion in 2030.
40% of 2025 revenue sits in Software, worth USD 120 billion and rising to USD 602 billion at 43% by 2034, the largest solution line in both years. Growth is fastest in Services at 21.13% and slowest in Hardware at 13.61%. Software and Services take share over the period; Hardware give it up while still growing in absolute terms.
The technology split puts Machine Learning first, at USD 126 billion and 42% of revenue in 2025, rising to USD 532 billion and 38% in 2034. Natural Language Processing (NLP) grows faster at 19.94% against 17.35%, moving from 20% of revenue to 22% by 2034. It cuts the same total as the solution axis from a different commercial angle, so revenue does not add across the two.
North America is the largest region at 39% of 2025 revenue, worth USD 117 billion and reaching USD 448 billion by 2034. Asia Pacific follows at 31%, moving from USD 93 billion to USD 574 billion, and Middle East and Africa is the smallest at 5%. Asia Pacific and Latin America gain share across the period, so growth is not distributed evenly between regions.
Behind these figures sit five regions, three solution lines and five segmentation axes, each reported for every year from 2020 to 2034. The headline 2025 value is arrived at by triangulating published aggregates against category proxies, not by an independent count, and the same applies to the segment, regional and country breakdowns drawn from it.
Market Size, 2020–2034
USD BillionRevenue in USD Billion. Values up to 2025 are actuals; 2026–2034 are forecast.
Key Takeaways
- A forecast-period rate of 17.55% takes the market from USD 300 billion in 2025 to USD 1400 billion in 2034, against 35.04% recorded over the 2020-2025 historical period.
- Software is the largest solution line at USD 120 billion in 2025, a 40% share, reaching USD 602 billion and 43% of revenue by 2034.
- Services is the fastest-growing line at 21.13%, lifting its share from 22% in 2025 to 29% in 2034 and its revenue from USD 66 billion to USD 406 billion.
- Scenario range for 2034 runs from USD 1190 billion in the bear case to USD 1610 billion in the bull case, against a base-case USD 1400 billion, the spread a plan built on this forecast has to absorb.
- North America holds 39% of global revenue in 2025 at USD 117 billion, the largest of the five regions tracked, and reaches USD 448 billion by 2034.
- Within North America, the United States is the worked country example, at USD 102.96 billion in 2025; 88% of regional revenue in the base year, and USD 389.76 billion by 2034.
- Fifteen years are reported, 2020 to 2034 with 2025 as the base: revenue, share and growth rate per line, per axis and per region, not as a single blended series.
Market Trends
Revenue Share, By by solution
Base year 2025Software leads with 40.0% of by solution segment revenue.
Share of by solution segment revenue, most recent base year.
The global artificial intelligence market is shaped over 2026-2034 by three measurable movements: a change in the solution mix, a shift in where revenue sits geographically, and the 17.55% rate carrying the total.
Not one of them points downward. Growth is everywhere in absolute terms, and the interest is entirely in where it lands.
Services outpaces Hardware. Between 2026 and 2034, 21.13% growth in Services against 13.61% in Hardware pulls the solution mix apart. Shares follow: 22% to 29% for Services, 38% to 28% for Hardware. The revenue figures behind that are USD 66 billion to USD 406 billion and USD 114 billion to USD 392 billion. Both expand; where a supplier sits on the axis still decides whether it tracks the market.
Growth concentrates in Asia Pacific and Latin America. Asia Pacific moves from 31% of revenue in 2025 to 41% in 2034, worth USD 93 billion rising to USD 574 billion; Latin America moves from 5% of revenue in 2025 to 5.5% in 2034, worth USD 15 billion rising to USD 77 billion. The offsetting side is North America at 39% moving to 32%, Europe at 20% moving to 17%, Middle East and Africa at 5% moving to 4.5%, none of which contracts. Growth is therefore not something a participant inherits from the market; it depends on which regions its revenue is weighted toward.
A continuation, not an inflection. Reading the series: USD 66.8 billion in 2020, USD 227.1 billion in 2024, USD 300 billion in 2025, USD 384 billion in 2026, USD 833 billion in 2030 and USD 1400 billion in 2034. There is no discontinuity to time, and 17.55% forecast growth against 35.04% historical means the trend continues and does not turn. That moves the planning question away from timing a turn and onto the solution and regional mixes, where the actual movement is.
Market Growth Factors
Growth is concentrated in Services
Market Drivers
3- 01Growth is concentrated in Services
At 21.13% against a market rate of 17.55%, Services is the line pulling the average up: USD 66 billion to USD 406 billion, and 22% of revenue to 29%. Set against 13.61% at the other end of the axis, this is the line that decides whether the market's 17.55% holds. That makes position on the solution axis a growth decision, not a product one.
- 02Growth lands where the revenue already is
39% of 2025 revenue (USD 117 billion) is generated in North America, reaching USD 448 billion by 2034 at an unchanged 32%. Asia Pacific adds a further 31% at USD 93 billion, reaching USD 574 billion. Together the two account for the majority of both the 2025 base and the revenue added by 2034, which is why a regional plan treating all five regions at equal weight misreads where the growth actually lands.
- 03Fifteen years of unbroken growth underpin the forecast
USD 66.8 billion in 2020, USD 227.1 billion in 2024 and USD 300 billion in 2025: 35.04% compound growth before the forecast period even begins. The forecast period then runs at 17.55%, ending 2034 at USD 1400 billion. With the trajectory already demonstrated over fifteen years, what remains uncertain is the mix, not the direction, which is where the segment and regional sections do the work.
Growth drivers
| # | Growth driver | Impact | Gross contribution (Billion) | 2026-28 | 2029-31 | 2032-34 |
|---|---|---|---|---|---|---|
| 1 | Enterprise generative AI adoption | High | +420 | High | High | Medium |
| 2 | Cloud infrastructure and compute scaling | High | +300 | High | High | Medium |
| 3 | Industrial and manufacturing automation demand | Medium-High | +220 | Medium | High | High |
| 4 | Healthcare diagnostic and clinical AI deployment | Medium-High | +150 | Medium | Medium | High |
| 5 | Financial services risk and analytics adoption | Medium | +80 | Medium | Medium | Medium |
| 6 | Others | Low | +10 | Low | Low | Low |
| Total | +1180 | |||||
Restraints
| # | Restraint | Impact | Estimated reduction (Billion) | 2026-28 | 2029-31 | 2032-34 |
|---|---|---|---|---|---|---|
| 1 | Data privacy and cross-border regulatory constraints | Medium | −50 | Medium | Medium | Low |
| 2 | High compute and energy costs limiting deployment scale | Medium | −30 | High | Medium | Low |
| Total | −80 | |||||
Drivers contribute 1180 Billion and restraints remove 80 Billion, a net 1100 Billion, which is the revenue the market adds between the base year and 2034. Contributions are CDI estimates, apportioned so that they reconcile with the forecast rather than being read from it.
Three sources account for the growth to 2034: 17.55% compounding across the base, share moving toward the faster solution lines, and above-market expansion in the leading regions.
Restraining Factors
Downside case: USD 1190 billion by 2034, against USD 1400 billion in the base case
Market Restraints
2- 01Downside case: USD 1190 billion by 2034, against USD 1400 billion in the base case
A bear case of USD 1190 billion in 2034, against USD 1400 billion in the base case, rests on one stated assumption: assumes enterprise AI budget growth slows toward the pace of general IT spending and regulatory approval timelines in healthcare and financial services lengthen, delaying deployment in the largest regulated end-use categories. Neither case changes the USD 300 billion 2025 base.
- 02Hardware holds the blended rate down
With 38% of 2025 revenue (USD 114 billion) Hardware is where most of the market sits, and it grows at only 13.61% against the market's 17.55%. Revenue still reaches USD 392 billion by 2034 and share still falls to 28%: a drag on the average, not a decline.
Market Opportunities
Upside case: USD 1610 billion by 2034
Market Opportunities
2- 01Upside case: USD 1610 billion by 2034
A bull case of USD 1610 billion by 2034, against USD 1400 billion in the base case, turns on a single stated assumption: assumes enterprise AI budgets continue compounding at their recent pace and compute prices keep falling faster than consumption grows, pulling adoption forward across every region. The USD 300 billion 2025 base is common to both.
- 02Services share moves from 22% to 29%
Share on the solution axis moves toward Services, from 22% in 2025 to 29% in 2034, on 21.13% growth against the market's 17.55% and revenue rising from USD 66 billion to USD 406 billion. Taking position there does not require displacing whoever holds Software, which is the harder and more expensive fight.
Market Challenges
Revenue is concentrated in Software
Market Challenges
2- 01Revenue is concentrated in Software
Software is 40% of 2025 revenue at USD 120 billion and still 43% at USD 602 billion in 2034. That concentration means the market's own forecast is, to a large extent, a forecast for one solution line.
- 02The United States is 88% of North America
Of North America's USD 117 billion in 2025, USD 102.96 billion (88%) comes from the United States alone, rising to USD 389.76 billion by 2034. Regional totals therefore move largely with one country's demand, so a regional forecast is more exposed to single-country conditions than its size alone suggests.
Segmentation Analysis
5 axesThe global artificial intelligence market is cut five ways: by solution, technology, end-use, law and deployment mode. They are alternative readings of one revenue pool, not parts that sum to it.
There are three lines on the solution axis, and all of them grow in revenue between 2025 and 2034. What separates them is share: two gain it, the other gives it up.
By Solution · 3 segments
Services Outpaces the Axis While Software Holds the Largest Share
- Largest Software · 40%
- Fastest Services · 21.1%
- Moves most Hardware · -10 pts
- Order by 2034 changes
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Hardware | $114B | 38% | $392B | 28%-10 | 13.6% |
| Software | $120B | 40% | $602B | 43%+3 | 18.5% |
| Services | $66B | 22% | $406B | 29%+7 | 21.1% |
Software leads because most enterprise budgets center on models, platforms and the licensing built around them, not the physical equipment underneath. Services is the fastest-growing line because deploying and maintaining AI systems inside existing enterprise processes takes more integration, customization and ongoing support work than buying software alone, and that work scales with every new deployment. Software remains the largest line through 2034, so the axis changes in proportion, not in order. Every year of the series is priced on this axis, making it the reference cut for the rest of the report.
By Technology · 4 segments
Natural Language Processing (NLP) Outpaces the Axis While Machine Learning Holds the Largest Share
- Largest Machine Learning · 42%
- Fastest Natural Language Processing (NLP) · 19.9%
- Moves most Machine Learning · -4 pts
- Order by 2034 unchanged
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Machine Learning | $126B | 42% | $532B | 38%-4 | 17.4% |
| Deep Learning | $84B | 28% | $420B | 30%+2 | 19.6% |
| Natural Language Processing (NLP) | $60B | 20% | $308B | 22%+2 | 19.9% |
| Machine Vision | $30B | 10% | $140B | 10% | 18.7% |
Machine Learning leads because it is the broadest and most established category, already embedded in analytics, recommendation and forecasting tools across industries. Natural Language Processing is growing fastest because conversational and document-generation applications have moved from experimental projects into everyday business tools much faster than other technology categories matured. By 2034 Machine Learning is still ahead, making this a shift in weight, not a change of leader.
By End-use · 13 segments
By End-use
- Largest Others · 25%
- Fastest Automated Image Diagnosis · 23.5%
- Moves most Others · -8 pts
- Order by 2034 changes
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Healthcare | $30B | 10% | $112B | 8%-2 | 15.8% |
| Robot-Assisted Surgery | $12B | 4% | $70B | 5%+1 | 21.7% |
| Virtual Nursing Assistants | $9B | 3% | $56B | 4%+1 | 22.5% |
| Hospital Workflow Management | $15B | 5% | $84B | 6%+1 | 21.1% |
| Dosage Error Reduction | $6B | 2% | $35B | 2.5%+0.5 | 21.7% |
| Clinical Trial Participant Identifier | $6B | 2% | $35B | 2.5%+0.5 | 21.7% |
| Preliminary Diagnosis | $18B | 6% | $112B | 8%+2 | 22.5% |
| Automated Image Diagnosis | $21B | 7% | $140B | 10%+3 | 23.5% |
| BFSI | $36B | 12% | $140B | 10%-2 | 16.3% |
| Risk Assessment | $24B | 8% | $126B | 9%+1 | 20.2% |
| Financial Analysis/Research | $27B | 9% | $140B | 10%+1 | 20.1% |
| Investment/Portfolio Management | $21B | 7% | $112B | 8%+1 | 20.4% |
| Others | $75B | 25% | $238B | 17%-8 | 13.7% |
2025 to 2034 revenue and share by line: Others USD 75 billion to USD 238 billion (25% in 2025), BFSI USD 36 billion to USD 140 billion (12% in 2025), Healthcare USD 30 billion to USD 112 billion (10% in 2025), Financial Analysis/Research USD 27 billion to USD 140 billion (9% in 2025), Risk Assessment USD 24 billion to USD 126 billion (8% in 2025), Automated Image Diagnosis USD 21 billion to USD 140 billion (7% in 2025), Investment/Portfolio Management USD 21 billion to USD 112 billion (7% in 2025), Preliminary Diagnosis USD 18 billion to USD 112 billion (6% in 2025), Hospital Workflow Management USD 15 billion to USD 84 billion (5% in 2025), Robot-Assisted Surgery USD 12 billion to USD 70 billion (4% in 2025), Virtual Nursing Assistants USD 9 billion to USD 56 billion (3% in 2025), Dosage Error Reduction USD 6 billion to USD 35 billion (2% in 2025), Clinical Trial Participant Identifier USD 6 billion to USD 35 billion (2% in 2025). Automated Image Diagnosis Outpaces the Axis While Others Holds the Largest Share Others leads because the category spans many smaller, still-emerging use cases across industries that have not yet grown large enough to be tracked individually. Automated Image Diagnosis is growing fastest because imaging-based AI tools have cleared more regulatory and clinical-validation milestones than other healthcare or financial-services applications, letting adoption move from pilot programs into routine clinical use more quickly. By 2034 Others is still ahead, making this a shift in weight, not a change of leader.
By Law · 6 segments
Manufacturing Held the Dominant Share of the Law Segment in 2025
- Largest Manufacturing · 28%
- Fastest Automotive & Transportation · 21.3%
- Moves most Automotive & Transportation · +4 pts
- Order by 2034 changes
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Retail | $60B | 20% | $266B | 19%-1 | 18% |
| Advertising & Media | $42B | 14% | $182B | 13%-1 | 17.7% |
| Automotive & Transportation | $54B | 18% | $308B | 22%+4 | 21.3% |
| Agriculture | $24B | 8% | $126B | 9%+1 | 20.2% |
| Manufacturing | $84B | 28% | $364B | 26%-2 | 17.7% |
| Others | $36B | 12% | $154B | 11%-1 | 17.5% |
Manufacturing leads because industrial automation, quality control and predictive maintenance were among the earliest and most measurable enterprise AI use cases, giving the segment a head start other verticals have not closed. Automotive and Transportation is growing fastest as advanced driver-assistance and autonomous-systems programs move from development into production vehicles, pulling in sustained hardware and software investment. The order does not change: Manufacturing is still largest in 2034, and what moves is how much it holds.
By Deployment Mode · 2 segments
Cloud Both Leads the Deployment mode Axis and Grows Fastest on It
- Largest Cloud · 62%
- Fastest Cloud · 20.7%
- Moves most Cloud · +10 pts
- Order by 2034 unchanged
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Cloud | $186B | 62% | $1008B | 72%+10 | 20.7% |
| On-Premise | $114B | 38% | $392B | 28%-10 | 14.7% |
Cloud leads because most enterprises consume AI capability through hosted platforms instead of owning and operating the underlying infrastructure themselves. It is also the fastest-growing option, since subscription pricing and managed-service delivery lower the barrier to adoption compared with the capital commitment that on-premise deployment still requires. Cloud remains the largest line through 2034, so the axis changes in proportion, not in order.
Regional Insights
Regional Revenue Share
Base year 2025
Share of global revenue in the base year.
Only the leading region's share is published outside the report; pins mark the region, not a specific country.
North America Market Analysis
The largest region covered — 7 points of share move elsewhere by 2034, while revenue still grows 3.8×.
- Rank 1 of 5
- 2025 share 39%
- By 2034 32%
- Revenue $117B → $448B
North America holds 39% of the global artificial intelligence market in 2025, worth USD 117 billion rising to USD 448 billion in 2034. That makes it the first-largest region covered, in 2025 and again in 2034.
By 2034 the share stands at 32%, though revenue still rises throughout; the shift is in the region's weight against faster-growing ones, which is not the same as weakening demand.
Software leads here as it does globally, at 40% of 2025 revenue, and Services again grows fastest at 21.13%. North America is reported axis by axis and country by country in the full study.
United States
Sets the pace for North America at 88% of it, growing 3.8×.
- In region 1 of 2
- Of region 88%
- Of global 34.3%
- Revenue $103B → $390B
USD 102.96 billion of North America's 2025 revenue is generated in the United States, the region's largest market, reaching USD 389.76 billion by 2034. At 88% of regional revenue in the base year it is not one market among several, the region's trajectory is largely this country's trajectory. Regional revenue of USD 117 billion in 2025 and USD 448 billion in 2034 sits around it, and it is the country used wherever the full report cuts a figure by geography.
the United States buys along the same lines as the market globally; Software first at 40% of 2025 revenue and 43% in 2034, Services fastest at 21.13% on a share moving from 22% to 29%. Since 88% of North America's revenue is generated here, the regional numbers inherit this market's mix instead of smoothing it out. Per-solution revenue for the United States appears on its own in the full report.
The United States has no single statute governing artificial intelligence; oversight instead runs through existing sectoral regulators and a national standards framework. The National Institute of Standards and Technology's AI Risk Management Framework sets the voluntary baseline that vendors are expected to align with when building or deploying models, covering governance, testing and documentation of risk. Agencies such as the Federal Trade Commission apply their existing consumer-protection and anti-discrimination authority to AI-driven decisions, while sector regulators, including the Food and Drug Administration for AI-enabled medical devices, layer on their own approval routes. A supplier operating in this market should expect to demonstrate risk assessment, bias testing and post-deployment monitoring rather than seek one federal AI licence, since none currently exists.
In the United States the field is Advanced Micro Devices, AiCure, Arm Limited, Atomwise, Inc., Ayasdi AI LLC, Baidu, Inc., Clarifai, Inc., Cyrcadia Health, Enlitic, Inc., Google LLC, H2O.ai., HyperVerge, Inc., International Business Machines Corporation, IBM Watson Health, Intel Corporation, Iris.ai AS., Lifegraph, Microsoft, NVIDIA Corporation, Sensely, Inc. and Zebra Medical Vision, Inc.. Software, at 40% of 2025 revenue, is where the volume sits, and Services, growing at 21.13%, is where position changes hands over the forecast period. Country-level shares and positioning per company sit in the full report.
Canada
2nd-largest in North America, growing 4.1×.
- In region 2 of 2
- Of region 12%
- Of global 4.7%
- Revenue $14.04B → $58.24B
Canada is sized at USD 14.04 billion in 2025, rising to USD 58.24 billion by 2034; 4.68% of global revenue and 12% of North America. It is reported separately from the United States across every segmentation axis in the full report.
Europe Market Analysis
The 3rd-largest region covered — 3 points of share move elsewhere by 2034, while revenue still grows 4.0×.
- Rank 3 of 5
- 2025 share 20%
- By 2034 17%
- Revenue $60B → $238B
In Europe, 20% of global revenue puts 2025 at USD 60 billion on the way to USD 238 billion by 2034. By revenue it sits third across the study, and the ranking does not change between 2025 and 2034.
Share settles at 17% in 2034, though revenue still rises throughout; the shift is in the region's weight against faster-growing ones, which is not the same as weakening demand.
Segment composition follows the global pattern: Software largest at 40% of 2025 revenue, Services fastest at 21.13%. Europe is reported axis by axis and country by country in the full study.
Germany
The largest market in Europe, growing 4.0×.
- In region 1 of 3
- Of region 30%
- Of global 6%
- Revenue $18B → $71.40B
USD 18 billion of Europe's 2025 revenue is generated in Germany, the region's largest market, reaching USD 71.4 billion by 2034. It accounts for 30% of regional revenue in the base year, the largest single share without dominating the region outright. The region itself runs USD 60 billion to USD 238 billion over the same period, and this is the market carrying the country-level detail in the full report.
Demand in Germany follows the solution mix reported at global level: Software is the largest line at 40% of 2025 revenue, moving to 43% by 2034, while Services grows fastest at 21.13% and takes its share from 22% to 29%. Since 30% of Europe's revenue is generated here, the regional numbers inherit this market's mix instead of smoothing it out. Germany carries its own solution breakdown in the full report.
Germany applies the EU Artificial Intelligence Act directly, since it is an EU regulation rather than a directive requiring national transposition. The Act classifies systems by risk tier, and a supplier placing a high-risk AI system on the German market must complete a conformity assessment, maintain technical documentation, and register the system before deployment. National oversight sits with a designated market surveillance authority working alongside the Federal Network Agency, which coordinates enforcement domestically. Providers must also meet the Act's transparency duties, disclosing when a user is interacting with an AI system, and align with harmonised standards issued under the European standardisation bodies. Data processing within these systems remains separately subject to the General Data Protection Regulation.
Competition in Germany runs between the suppliers this study tracks: Advanced Micro Devices, AiCure, Arm Limited, Atomwise, Inc., Ayasdi AI LLC, Baidu, Inc., Clarifai, Inc., Cyrcadia Health, Enlitic, Inc., Google LLC, H2O.ai., HyperVerge, Inc., International Business Machines Corporation, IBM Watson Health, Intel Corporation, Iris.ai AS., Lifegraph, Microsoft, NVIDIA Corporation, Sensely, Inc. and Zebra Medical Vision, Inc.. The commercially relevant division is 40% of 2025 revenue in Software, where the volume is, against 21.13% growth in Services, where share moves. A supplier weighted toward Europe is competing over a base of USD 60 billion in 2025 reaching USD 238 billion by 2034, 20% of global revenue at the start of that period.
United Kingdom
2nd-largest in Europe, growing 4.0×.
- In region 2 of 3
- Of region 25%
- Of global 5%
- Revenue $15B → $59.50B
Within Europe, the United Kingdom accounts for 25% of regional revenue and 5% of the global total, worth USD 15 billion in 2025 and USD 59.5 billion by 2034.
France
3rd-largest in Europe, growing 4.0×.
- In region 3 of 3
- Of region 20%
- Of global 4%
- Revenue $12B → $47.60B
Within Europe, France accounts for 20% of regional revenue and 4% of the global total, worth USD 12 billion in 2025 and USD 47.6 billion by 2034.
Asia Pacific Market Analysis
The 2nd-largest region covered, and the one gaining the most — it picks up 10 points of share by 2034, while revenue still grows 6.2×.
- Rank 2 of 5
- 2025 share 31%
- By 2034 41%
- Revenue $93B → $574B
31% of the global artificial intelligence market sits in Asia Pacific in 2025, worth USD 93 billion and reaches USD 574 billion by 2034. That makes it the second-largest region covered, in 2025 and again in 2034.
41% of global revenue sits here by 2034, up from the 2025 level, so the region grows faster than the market's 17.55% and takes a larger part of the revenue added by 2034 than its 2025 weight implies.
The solution mix reported at global level applies here, with Software the largest line at 40% of 2025 revenue and Services the fastest-growing at 21.13%. Per-axis and per-country detail for Asia Pacific sits in the full report.
China
The largest market in Asia Pacific, growing 6.2×.
- In region 1 of 3
- Of region 45%
- Of global 13.9%
- Revenue $41.85B → $258B
The largest single market in Asia Pacific is China, at USD 41.85 billion in 2025 and USD 258.3 billion in 2034. It accounts for 45% of regional revenue in the base year, the largest single share without dominating the region outright. The region itself runs USD 93 billion to USD 574 billion over the same period, and this is the market carrying the country-level detail in the full report.
The solution pattern in China is the global one: 40% of 2025 revenue in Software, 43% by 2034, against 21.13% growth in Services taking it from 22% to 29%. With 45% of Asia Pacific concentrated here, a change in this country's mix is visible in the regional figures instead of being diluted by its neighbours. Revenue by solution for China is reported separately in the full report.
China regulates artificial intelligence through the Cyberspace Administration of China, which administers a filing and security assessment regime for algorithms that shape public opinion or influence social mobilisation. Generative AI services aimed at the public fall under the Interim Measures for the Management of Generative Artificial Intelligence Services, requiring providers to complete a security assessment, register their algorithms, and ensure training data and outputs align with content-management rules set by the state. Suppliers must also label AI-generated content so it is distinguishable to users, following the Administration's provisions on synthetic content. Cross-border data transfers tied to model training face separate review under China's data security and personal information protection framework.
Advanced Micro Devices, AiCure, Arm Limited, Atomwise, Inc., Ayasdi AI LLC, Baidu, Inc., Clarifai, Inc., Cyrcadia Health, Enlitic, Inc., Google LLC, H2O.ai., HyperVerge, Inc., International Business Machines Corporation, IBM Watson Health, Intel Corporation, Iris.ai AS., Lifegraph, Microsoft, NVIDIA Corporation, Sensely, Inc. and Zebra Medical Vision, Inc. are the suppliers covered in China. Two different problems sit on the same axis: holding Software at 40% of 2025 revenue, and taking Services while it grows at 21.13%. That makes Asia Pacific a 31% share of 2025 global revenue, USD 93 billion rising to USD 574 billion, for any supplier deciding where to concentrate.
Japan
2nd-largest in Asia Pacific, growing 6.2×.
- In region 2 of 3
- Of region 20%
- Of global 6.2%
- Revenue $18.60B → $115B
Within Asia Pacific, Japan accounts for 20% of regional revenue and 6.2% of the global total, worth USD 18.6 billion in 2025 and USD 114.8 billion by 2034.
India
3rd-largest in Asia Pacific, growing 6.2×.
- In region 3 of 3
- Of region 15%
- Of global 4.7%
- Revenue $13.95B → $86.10B
4.65% of global revenue is generated in India; USD 13.95 billion in 2025, reaching USD 86.1 billion in 2034, and 15% of Asia Pacific.
Latin America Market Analysis
The 4th-largest region covered — it picks up 0.5 points of share by 2034, while revenue still grows 5.1×.
- Rank 4 of 5
- 2025 share 5%
- By 2034 5.5%
- Revenue $15B → $77B
USD 15 billion of 2025 revenue is generated in Latin America, 5% of the global artificial intelligence market on the way to USD 77 billion by 2034. Among the five regions it ranks fourth by revenue in both years.
Its share rises to 5.5% over the forecast period, on growth above the market's own 17.55%, and with a bigger contribution to the revenue added over the period than the base-year figure suggests.
Within the region the solution split tracks the global one; 40% of 2025 revenue in Software, fastest growth of 21.13% in Services. Per-axis and per-country detail for Latin America sits in the full report.
Brazil
The largest market in Latin America, growing 5.1×.
- In region 1 of 2
- Of region 55%
- Of global 2.8%
- Revenue $8.25B → $42.35B
Brazil is the largest market within Latin America, generating USD 8.25 billion in 2025 and projected to reach USD 42.35 billion by 2034. At 55% of the region in 2025 it leads, but a majority of Latin America's revenue is generated in other markets. The region itself runs USD 15 billion to USD 77 billion over the same period, and this is the market carrying the country-level detail in the full report.
Demand in Brazil follows the solution mix reported at global level: Software is the largest line at 40% of 2025 revenue, moving to 43% by 2034, while Services grows fastest at 21.13% and takes its share from 22% to 29%. Because the country carries 55% of Latin America, a movement in its own mix shows up in the regional totals instead of being averaged away by neighbouring markets. Brazil carries its own solution breakdown in the full report.
Brazil does not yet have a dedicated artificial intelligence statute in force, so oversight currently rests on the National Data Protection Authority applying the Lei Geral de Proteção de Dados to automated decision-making, including a right for individuals to request review of decisions made solely by an algorithm. A general AI framework has progressed through the national congress and would introduce risk-based obligations, including impact assessments and registration duties for higher-risk systems, though its final form and effective date remain pending. Suppliers active in this market are expected to document how personal data feeds model training, disclose automated decision-making to affected users, and monitor the legislative process closely given how much of the eventual compliance burden is still being settled.
In Brazil the field is Advanced Micro Devices, AiCure, Arm Limited, Atomwise, Inc., Ayasdi AI LLC, Baidu, Inc., Clarifai, Inc., Cyrcadia Health, Enlitic, Inc., Google LLC, H2O.ai., HyperVerge, Inc., International Business Machines Corporation, IBM Watson Health, Intel Corporation, Iris.ai AS., Lifegraph, Microsoft, NVIDIA Corporation, Sensely, Inc. and Zebra Medical Vision, Inc.. The commercially relevant division is 40% of 2025 revenue in Software, where the volume is, against 21.13% growth in Services, where share moves. The commercial size of that position is USD 15 billion in 2025 and USD 77 billion by 2034, 5% of the global total in the base year.
Mexico
2nd-largest in Latin America, growing 5.1×.
- In region 2 of 2
- Of region 30%
- Of global 1.5%
- Revenue $4.50B → $23.10B
1.5% of global revenue is generated in Mexico; USD 4.5 billion in 2025, reaching USD 23.1 billion in 2034, and 30% of Latin America.
Middle East and Africa Market Analysis
The 5th-largest region covered — 0.5 points of share move elsewhere by 2034, while revenue still grows 4.2×.
- Rank 5 of 5
- 2025 share 5%
- By 2034 4.5%
- Revenue $15B → $63B
5% of the global artificial intelligence market sits in Middle East and Africa in 2025, worth USD 15 billion rising to USD 63 billion in 2034. It is a marginal region on this axis, fifth by revenue throughout the period.
4.5% of global revenue sits here in 2034, below the 2025 level, and the region keeps growing in absolute terms while others expand faster, a change in relative weight, not a decline in demand.
Within the region the solution split tracks the global one; 40% of 2025 revenue in Software, fastest growth of 21.13% in Services. Per-axis and per-country detail for Middle East and Africa sits in the full report.
United Arab Emirates
The largest market in Middle East and Africa, growing 4.2×.
- In region 1 of 2
- Of region 35%
- Of global 1.8%
- Revenue $5.25B → $22.05B
The largest single market in Middle East and Africa is the United Arab Emirates, at USD 5.25 billion in 2025 and USD 22.05 billion in 2034. At 35% of the region in 2025 it leads, but a majority of Middle East and Africa's revenue is generated in other markets. The region itself runs USD 15 billion to USD 63 billion over the same period, and this is the market carrying the country-level detail in the full report.
the United Arab Emirates buys along the same lines as the market globally; Software first at 40% of 2025 revenue and 43% in 2034, Services fastest at 21.13% on a share moving from 22% to 29%. Its 35% weight in Middle East and Africa means those movements carry straight into the regional totals. Per-solution revenue for the United Arab Emirates appears on its own in the full report.
The United Arab Emirates governs artificial intelligence through a federal strategy overseen by the AI and Digital Economy Council together with the Telecommunications and Digital Government Regulatory Authority, which issues guidance and ethical charters that suppliers are expected to follow rather than a single binding product law. Sector regulators apply their own requirements where AI is embedded in a regulated activity, so a health-related deployment must still satisfy the Ministry of Health and Prevention or the relevant emirate-level health authority, and a financial application falls under the Central Bank or the applicable financial free-zone regulator. Data handling within these systems is separately governed by federal and free-zone data protection law, and suppliers are generally expected to maintain transparency and human oversight in how systems reach decisions.
Advanced Micro Devices, AiCure, Arm Limited, Atomwise, Inc., Ayasdi AI LLC, Baidu, Inc., Clarifai, Inc., Cyrcadia Health, Enlitic, Inc., Google LLC, H2O.ai., HyperVerge, Inc., International Business Machines Corporation, IBM Watson Health, Intel Corporation, Iris.ai AS., Lifegraph, Microsoft, NVIDIA Corporation, Sensely, Inc. and Zebra Medical Vision, Inc. are the suppliers covered in the United Arab Emirates. Two different problems sit on the same axis: holding Software at 40% of 2025 revenue, and taking Services while it grows at 21.13%. That makes Middle East and Africa a 5% share of 2025 global revenue, USD 15 billion rising to USD 63 billion, for any supplier deciding where to concentrate.
Saudi Arabia
2nd-largest in Middle East and Africa, growing 4.2×.
- In region 2 of 2
- Of region 30%
- Of global 1.5%
- Revenue $4.50B → $18.90B
1.5% of global revenue is generated in Saudi Arabia; USD 4.5 billion in 2025, reaching USD 18.9 billion in 2034, and 30% of Middle East and Africa.
Request this sample to see the full data tables and segment-level detail behind this analysis.
Report Coverage
This report assesses the market across every segment, with revenue and a growth rate for each line in each year of the study period. It covers the drivers, trends, opportunities, restraints and challenges shaping growth, the competitive landscape and the companies profiled, and the research methodology behind every estimate. Segmentation is reported by solution, technology, end-use, law, deployment mode, and regional analysis covers North America, Europe, Asia Pacific, Latin America, Middle East and Africa, each broken out by country.
Competitive Landscape
Suppliers Compete on Software Volume and Services Momentum
The field covered here is Advanced Micro Devices, AiCure, Arm Limited, Atomwise, Inc., Ayasdi AI LLC, Baidu, Inc., Clarifai, Inc., Cyrcadia Health, Enlitic, Inc., Google LLC, H2O.ai., HyperVerge, Inc., International Business Machines Corporation, IBM Watson Health, Intel Corporation, Iris.ai AS., Lifegraph, Microsoft, NVIDIA Corporation, Sensely, Inc. and Zebra Medical Vision, Inc..
Competition follows the solution split, not the regional one. The largest block of revenue is Software: USD 120 billion in 2025 at 40% of the total, 43% in 2034. Incumbency there is expensive to challenge. Movement is concentrated in Services; 21.13% growth, against 13.61% at the other end of the axis in Hardware. Holding the first and taking the second are separate capabilities, which is why a market of USD 300 billion supports as many suppliers as it does.
Compute and data access separate the largest suppliers from the rest: hyperscale cloud platforms and chip designers can train and serve models at a cost smaller vendors cannot match, and that advantage compounds as model sizes grow. Regulatory and clinical experience is a second axis; healthcare and financial-services buyers weight a vendor's track record with approval and compliance processes before granting access to sensitive workflows. Smaller and regional suppliers compete on domain-specific tuning, integration speed and pricing flexibility, often reaching customers through a larger platform's ecosystem instead of building their own infrastructure. Existing enterprise relationships also shape many purchase decisions as much as model performance does.
The regional picture sets the entry cost: 39% of revenue is in North America and 31% in Asia Pacific, so a credible global position requires both, while Middle East and Africa at 5% can be served opportunistically.
Per-company profiles, financials, share and development history are in the full report and not here.
List of Key Artificial Intelligence Market Companies Profiled
21 companies profiled. Company profiles, including financials, product portfolios and recent developments, are part of the full report.
- Advanced Micro Devices(United States)
- AiCure(United States)
- Arm Limited(United Kingdom)
- Atomwise, Inc.(United States)
- Ayasdi AI LLC(United States)
- Baidu, Inc.(China)
- Clarifai, Inc.(United States)
- Cyrcadia Health(United States)
- Enlitic, Inc.(United States)
- Google LLC(United States)
- H2O.ai.(United States)
- HyperVerge, Inc.(United States)
- International Business Machines Corporation(United States)
- IBM Watson Health(United States)
- Intel Corporation(United States)
- Iris.ai AS.(Norway)
- Lifegraph
- Microsoft(United States)
- NVIDIA Corporation(United States)
- Sensely, Inc.(United States)
- Zebra Medical Vision, Inc.(Israel)
Geographic Coverage
Every market below is broken out separately in the report.
North America
3Europe
8Asia Pacific
12Latin America
3Middle East and Africa
4Key Insights
Report Scope
Study parameters & segmentationThis study covers market size and forecasts over the 2020–2034 period, segmentation across 5 axes (Solution, Technology, End-use, Law, Deployment Mode), regional analysis for 5 regions and their constituent countries, a competitive landscape profiling 21 key companies, and the research methodology behind every estimate.
Segmentation
5 axes + regionFull chapter-and-section structure of the report. Segment, region, and company breakdowns are listed as scope. The underlying figures are in the sample and full report.
Table of Contents+−
Chapter 1.Executive Summary
Chapter 2.Premium Insights
Chapter 3.Market Definition
Chapter 4.Research Methodology
Chapter 5.Strategic Imperatives & Market Outlook
Chapter 6.Go-to-Market (GTM) Strategies
Chapter 7.Market Trends, Strategy & Dynamics
Chapter 8.Porter's Five Forces
Chapter 9.PESTEL Analysis
Chapter 10.Value Chain Analysis
Chapter 11.Supply Chain Analysis
Chapter 12.Macro-Economic Factors
Chapter 13.Market Cost Analysis
Chapter 14.Market Supply-Side Analysis
Chapter 15.Global Artificial Intelligence Market Size & Projections, 2020–2034, Revenue (USD Billion)
Chapter 16.Global Artificial Intelligence Market Overview, By Solution, 2020–2034, Revenue (USD Billion)
Chapter 17.Global Artificial Intelligence Market Overview, By Technology, 2020–2034, Revenue (USD Billion)
Chapter 18.Global Artificial Intelligence Market Overview, By End-use, 2020–2034, Revenue (USD Billion)
Chapter 19.Global Artificial Intelligence Market Overview, By Law, 2020–2034, Revenue (USD Billion)
Chapter 20.Global Artificial Intelligence Market Overview, By Deployment Mode, 2020–2034, Revenue (USD Billion)
Chapter 21.Global Artificial Intelligence Market Size — Segment Comparison
Chapter 22.Global Artificial Intelligence Geography Overview, 2020–2034, Revenue (USD Billion)
Chapter 23.North America Artificial Intelligence Market Deep-Dive, 2020–2034, Revenue (USD Billion)
Chapter 24.Europe Artificial Intelligence Market Deep-Dive, 2020–2034, Revenue (USD Billion)
Chapter 25.Asia Pacific Artificial Intelligence Market Deep-Dive, 2020–2034, Revenue (USD Billion)
Chapter 26.Latin America Artificial Intelligence Market Deep-Dive, 2020–2034, Revenue (USD Billion)
Chapter 27.Middle East and Africa Artificial Intelligence Market Deep-Dive, 2020–2034, Revenue (USD Billion)
Chapter 28.Application / Use-Case Analysis
Chapter 29.Vendor Capability Scorecard
Chapter 30.Scenario Forecasts
Chapter 31.Top 10 Key Clients of Top 10 Players
Chapter 32.Top 10 Suppliers
Chapter 33.Competitive Landscape
Chapter 34.Partnerships & M&A
Chapter 35.Key Vendor Analysis
Chapter 36.Marketing Strategy Analysis, Distributors & Traders
Chapter 37.Outlook of the Market
Chapter 38.Concluding Analyst Note
List of Figures+−
Structural index generated from this report's own section headings, not verified against the delivered report's actual figure numbering.
List of Tables+−
Structural index generated from this report's own section headings, not verified against the delivered report's actual table numbering.
Segmentation Analysis
5 axesBy Solution
3- 01Hardware
- 02Software
- 03Services
By Technology
4- 01Machine Learning
- 02Deep Learning
- 03Natural Language Processing (NLP)
- 04Machine Vision
By End-use
13- 01Healthcare
- 02Robot-Assisted Surgery
- 03Virtual Nursing Assistants
- 04Hospital Workflow Management
- 05Dosage Error Reduction
- 06Clinical Trial Participant Identifier
- 07Preliminary Diagnosis
- 08Automated Image Diagnosis
- 09BFSI
- 10Risk Assessment
- 11Financial Analysis/Research
- 12Investment/Portfolio Management
- 13Others
By Law
6- 01Retail
- 02Advertising & Media
- 03Automotive & Transportation
- 04Agriculture
- 05Manufacturing
- 06Others
By Deployment Mode
2- 01Cloud
- 02On-Premise
Segment categories shown for scope reference. See the Summary tab for revenue share by By Solution. Full segment-by-segment detail across every axis is available in the sample and full report.
Research approach
A market size is a claim about the world, and a claim is only as good as the route to it. Every study is built upward from units and prices — what is actually produced, sold or performed, at what it actually changes hands for — rather than from a headline figure divided downwards. Disclosed company revenue is then used to check that build, not to produce it.
Sizing starts from the bottom up: unit shipments of AI-capable processors and accelerators, the number of enterprise software seats and API-consumption units sold, and the realised price per unit or per subscription tier in each region. Hardware volume is anchored to processor shipment data and average selling prices by chip class; software and services revenue is built from seat counts, consumption-based pricing and typical contract values reported across the vendor base covered in this study. That build is then checked against disclosed segment revenue in the annual filings of the largest listed suppliers named in this report. Where a unit-price or attach-rate assumption produced a total that diverged from disclosed figures, the bottom-up assumption was revisited and corrected rather than averaged against the disclosed number.
The four stages
The same sequence runs behind every published study, whatever the industry. The order matters as much as the steps: the segment axes are fixed before any number is collected, so the model is never reshaped to fit whatever data happens to turn up.
What the build rests on, and what checks it
The two are not interchangeable. The left column produces the number; the right column tests it. When the check disagrees with the build, the answer is to find which bottom-up assumption is wrong — a unit count, a price, a take-up rate — not to split the difference between them.
- Volume actually transacted — units produced, installed, dispensed or procedures performed, counted at the level each is genuinely recorded
- Realised pricing by tier and channel, rather than one blended average applied across the whole market
- Take-up and frequency: how much of the addressable base buys, and how often it repeats
- Disclosed revenue of the companies serving the market, where filings separate it far enough to be usable
- Buyer-side spending totals — capital budgets, procurement lines, or the output of the end market the product is bought against
- Trade and customs flows, where the product crosses borders in a separately recorded form
Data sources
Published data establishes what happened. Only the people transacting in a market can say why, and what is about to change — so the two are collected separately and weighted differently.
- Commercial and product leadership at the companies that supply the market
- Procurement and specification leads at the organisations that buy it
- Distributors, integrators and channel partners, where the market is served indirectly
- Regulatory and standards specialists, where approval governs what can be sold at all
- Company filings, annual reports and investor disclosure
- Government statistics, customs records and regulatory registers
- Trade association output and standards-body publications
- Technical and peer-reviewed literature, where the market rests on a clinical or engineering claim
Primary research is directed at the commercial and technical roles that decide AI purchases and set pricing: product and platform leads at software and hardware vendors, IT and data-science leaders at enterprise buyers, channel and systems-integration partners, and compliance or risk officers at regulated buyers in healthcare and financial services. Procurement contacts are included to confirm realised contract values and renewal terms, not list prices alone. Sampling is weighted toward North America and Asia Pacific, where the largest share of vendor revenue and enterprise deployment activity originates, with additional coverage in Europe to capture regulatory-driven adoption patterns and in the Middle East and Latin America to track early-stage enterprise rollout.
Secondary research draws on the SEC 10-K and 10-Q filings of listed hardware, software and cloud vendors for segment-level revenue and capital-expenditure disclosure, customs trade-flow data filed under HS code 8542 for processor and accelerator shipments, and semiconductor industry association shipment and pricing benchmarks. AI-specific patent activity is tracked through WIPO's G06N patent classification to gauge where research and development investment is concentrated by country. Public-sector procurement disclosures and national AI-strategy funding announcements are used to size government and defence-adjacent demand, and telecom and cloud operators' own capacity-expansion disclosures inform the infrastructure side of the build.
Desk research runs across proprietary research databases including Factiva, OneSource and Hoovers alongside the public sources above. Modelling and statistical validation are run in SAS and SPSS.
Forecasting
The forecast is not a growth rate applied to a base year. It is built from the drivers that are expected to change, each one stated so a reader can disagree with it.
The forecast is built segment by segment from expected unit growth in processors and compute capacity, seat and consumption growth in software, and rising services attach rates as enterprises move from pilots to production deployment. Regulatory timelines for AI use in healthcare and financial services are modelled explicitly, since approval pace gates how quickly regulated-sector revenue can scale, not raw technical readiness. Pricing is assumed to keep falling per unit of compute while total consumption rises faster than that decline, matching the historical pattern. The forecast treats the compressed early-2023 pricing spike in specialised AI processors as a temporary supply constraint, not a new baseline. Holding this path requires enterprise AI budgets to keep growing in line with recent years.
Triangulation and validation
No figure enters a report on the strength of one source. Where the two sizing routes disagree the difference is not averaged away — the assumption causing it is isolated, tested against a third independent measure, and either corrected or carried forward as a stated limitation. Historical years are back-tested against the growth actually recorded before any forecast is allowed to run forward from them.
Outputs are checked against recorded growth in the historical period: the 2020-2024 build is compared year by year against disclosed vendor revenue growth rates to confirm the bottom-up assumptions do not drift from what already happened. Segment analysts review shifts in the solution and technology mix against known product launches and pricing changes reported by covered vendors, flagging any sub-segment whose implied share change looks larger than the underlying volume data supports. Sensitivity ranges were tested on the two assumptions the forecast is most exposed to: the pace of compute-price decline and the rate at which regulated-sector approval processes clear new AI use cases. Regional splits were cross-checked against reported cloud-infrastructure capacity additions by geography for consistency.
Confidence and limitations
Where an estimate is firm and where it is not is stated rather than left to be inferred from the precision of the number.
Confidence is highest for the hardware and cloud-infrastructure segments, where processor shipment volumes and hyperscaler capital spending are disclosed regularly and can be checked against multiple independent sources. It is lower for services revenue, where consulting and integration work is often bundled into broader enterprise contracts and reported inconsistently across vendors, and for country-level splits outside North America, Europe and the leading Asia Pacific markets, where public disclosure is thinner. The clearest risk to this estimate is a slowdown in enterprise AI budget growth from its recent pace; a second is faster-than-expected commoditisation of model capability, which would compress software pricing across the forecast.
Every report purchase includes direct access to the lead analyst for scoping questions on the data, at no extra cost and with no separate booking process.
Request a tailored breakdown by geography, segment, or competitor set beyond what's in the standard report.
Questions This Report Answers
6 questionsWhat is the market size and growth rate, globally and by region?
How is the market segmented, and which segments lead?
Which regions and countries are covered, and how do they compare?
What are the key drivers, restraints, opportunities and challenges?
Who are the leading companies operating in this market?
What trends are expected to shape the market through the forecast period?
Frequently Asked Questions
01What is the Artificial Intelligence Market projected to reach?
USD 1400 Billion by 2034, CAGR 17.55%
02What years does this report cover?
Study period 2020–2034, base year 2025, historical data 2020-2024, forecast period 2026-2034.
03Which regions are covered?
North America, Europe, Asia Pacific, Latin America, Middle East and Africa.
04Which region accounted for the largest market share?
North America leads with 39% of global revenue through 2034.
05Which segment leads the market?
Software is the largest line by solution, at 40% of revenue in 2025.
06Who are the key companies profiled?
Advanced Micro Devices, AiCure, Arm Limited, Atomwise, Inc., Ayasdi AI LLC, Baidu, Inc., Clarifai, Inc., Cyrcadia Health, Enlitic, Inc., Google LLC, H2O.ai., HyperVerge, Inc., International Business Machines Corporation, IBM Watson Health, Intel Corporation, Iris.ai AS., Lifegraph, Microsoft, NVIDIA Corporation, Sensely, Inc., Zebra Medical Vision, Inc.. Full profiles are part of the paid report.
07Can the segmentation be customized?
Yes. Custom data cuts by geography, segment, or competitor set are available on request.
Why choose CDI
Need this report shaped around your question?
The scope isn't fixed. Tell us what your team needs that the standard edition doesn't cover, and an analyst will come back on what can be adjusted and how long it takes, before you commit to anything.
Most licences include 30–60 hours of customization at no extra cost. See what each licence includes
Additional Companies
Add competitors, suppliers or the peer set you benchmark against to the companies already covered.
Deeper Competitive View
Sharpen the landscape work around your own position: product line, channel, or a named shortlist of rivals.
Extra Segment Splits
Break the market down along an axis the standard scope doesn't cut it by, or go a level deeper inside one.
Application Focus
Narrow the analysis to the specific use cases and end users your team actually sells into.
Different Time Frame
Move the base year, or widen the historical and forecast windows the study is built on.
Country-Level Detail
Go below region level into the individual countries that matter to you, rather than the standard geography split.